AEMD Aethlon Medical Inc
Price (delayed)
$0.5834
Market cap
$8.43M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.58
Enterprise value
$4.21M
Aethlon is focused on addressing unmet needs in global health. The Aethlon Hemopurifier is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. In cancer, the Hemopurifier
Highlights
Aethlon Medical's EPS has surged by 68% YoY and by 44% QoQ
The net income has increased by 22% year-on-year and by 15% since the previous quarter
Aethlon Medical's gross profit has shrunk by 100% YoY
AEMD's revenue has plunged by 100% YoY
Key stats
What are the main financial stats of AEMD
Market
Valuations
Earnings
Shares outstanding
14.46M
Market cap
$8.43M
Enterprise value
$4.21M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.88
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$9.82M
Net income
-$9.56M
EBIT
-$9.56M
EBITDA
-$9.22M
Free cash flow
-$8.55M
Per share
Balance sheet
Liquidity
EPS
-$1.58
EPS diluted
-$1.58
Free cash flow per share
-$0.61
Book value per share
$0.31
Revenue per share
$0
TBVPS
$0.47
Total assets
$6.53M
Total liabilities
$2.19M
Debt
$724,848
Equity
$4.33M
Working capital
$3.19M
Debt to equity
0.17
Current ratio
2.8
Quick ratio
2.79
Net debt/EBITDA
0.46
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-109.1%
Return on equity
-154%
Return on invested capital
-1,056.8%
Return on capital employed
-201.2%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AEMD stock price
How has the Aethlon Medical stock price performed over time
Intraday
-4.25%
1 week
-5.23%
1 month
-10.9%
1 year
-65.68%
YTD
-32.16%
QTD
-32.16%
Financial performance
How have Aethlon Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$9.82M
Net income
-$9.56M
Gross margin
N/A
Net margin
N/A
Aethlon Medical's gross profit has shrunk by 100% YoY
AEMD's revenue has plunged by 100% YoY
The company's operating income rose by 22% YoY and by 15% QoQ
The net income has increased by 22% year-on-year and by 15% since the previous quarter
Growth
What is Aethlon Medical's growth rate over time
Valuation
What is Aethlon Medical stock price valuation
P/E
N/A
P/B
1.88
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Aethlon Medical's EPS has surged by 68% YoY and by 44% QoQ
The company's equity fell by 43% YoY and by 28% QoQ
The P/B is 34% above the 5-year quarterly average of 1.4 and 34% above the last 4 quarters average of 1.4
AEMD's revenue has plunged by 100% YoY
Efficiency
How efficient is Aethlon Medical business performance
Aethlon Medical's ROIC has decreased by 45% YoY but it has increased by 4.9% from the previous quarter
The ROE has contracted by 45% YoY but it has grown by 4% from the previous quarter
The ROA has contracted by 26% YoY but it has grown by 6% from the previous quarter
Dividends
What is AEMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AEMD.
Financial health
How did Aethlon Medical financials performed over time
The company's total assets is 198% higher than its total liabilities
The company's total assets fell by 37% YoY and by 26% QoQ
Aethlon Medical's current ratio has decreased by 29% YoY and by 8% QoQ
The company's debt is 83% lower than its equity
The debt to equity has surged by 70% year-on-year and by 31% since the previous quarter
The company's equity fell by 43% YoY and by 28% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.